Health Highlight: Fri. 3, Mar.
Today’s highlights: Understanding pathological narcissism; FDA’s Office of Generic Drugs 2022 report recap; Colorectal cancer risk and Millennials.
Health Highlights workflow is powered by Glasp.co
🧠 Learn, ❤️ Like, 🤝 Share, and 📩 Subscribe
🔗: A little bit of narcissism is normal and healthy – here’s how to tell when it becomes pathological
✍🏼 By: April Nisan Ilkmen • @ConversationUS
Summary: Narcissism is normal in small amounts, but when it becomes extreme, it can be dangerous. The word "narcissism" is used more often now because of social media, but it's important to know the difference between normal and pathological narcissism.
Context: There are two types of narcissism, normal and pathological. Pathological narcissism is characterized by extreme changes in emotions from inferiority to superiority.
Supporting information: Pathological narcissism includes traits such as seeing others as an extension of themselves, choosing partners that support their sense of superiority, gaslighting, victim mentality, and a cycle of idealization and devaluation.
Analysis: Effective therapy for couples dealing with pathological narcissism is rare but possible if the narcissistic partner acknowledges their behavior.
Conclusion: Knowing the difference between normal and pathological narcissism can help people identify when it becomes dangerous and seek help.
#Narcissism #Personalitydisorders#NarcissisticPersonalityDisorder #Gaslighting
🔗: Collaboration and Scientific Innovation Stimulated Advancement in the Generic Drug Program in 2022
✍🏼 By: FDA Voices Staff Writer • @US_FDA
Summary: In 2022, the US FDA's Office of Generic Drugs did a lot of good work. Hundreds of generic drugs were approved, and international partnerships grew.
Context: Congress authorized the Generic Drug User Fee Amendments (GDUFA) III, which went into effect on Oct. 1, 2022, enabling the FDA to advance scientific research through the GDUFA Science and Research Program.
Support Info: The GDUFA Science and Research Program helps ensure regulatory standards are based on current scientific evidence.
Analysis: The FDA is actively engaged in collaboration with regulatory authorities worldwide to harmonize standards for the development of safe, effective, high-quality generic medicines.
Conclusion: The FDA’s approval of hundreds of generic drugs, including complex generics, and their efforts in scientific research and international collaborations contribute to the availability and affordability of high-quality generic medicines.
#FDA #GDUFA #OGD #PrescriptionMedications #GenericDrugs
🔗: Mayo Clinic Minute: Why millennials should know colon cancer symptoms
✍🏼 By: Deb Balzer @MayoClinic
Summary: Colon cancer is being found in a growing number of younger adults in its later stages. Symptoms don't usually show up in the early stages, but stomach pain that doesn't go away and weight loss that can't be explained can be signs.
Context: The U.S. Preventive Services Task Force and the American Cancer Society recommend screening for colorectal cancer at age 45 for patients of average risk.
Support Info: Alaska Natives, American Indians, and African Americans have a greater risk of colon cancer than people of other races.
Analysis: The article stresses the importance of awareness and early detection of colon cancer for younger adults, as symptoms may not appear until the later stages of the disease.
Conclusion: Patients are encouraged to speak with their healthcare provider about personalized recommendations for screening, particularly those with a family history or who are of higher risk due to race.
#Colorectalcancer #CancerScreening #Millennials #CancerRisk
Super insightful!
Thanks for sharing!!!